Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03809624
Title Study of INBRX-105 in Patients With Solid Tumors (PDL1x41BB)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Inhibrx, Inc.
Indications

renal cell carcinoma

lung non-small cell carcinoma

melanoma

gastric adenocarcinoma

Hodgkin's lymphoma

Advanced Solid Tumor

non-Hodgkin lymphoma

transitional cell carcinoma

gastroesophageal junction adenocarcinoma

head and neck squamous cell carcinoma

Therapies

INBRX-105

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST